Artera vs Hyro (2026)
The two established healthcare communication platforms, and they overlap enough that most buyers will see both in the same evaluation. Artera is the broader patient journey platform, orchestrating agents across voice, text and web at very large scale, with named integrations into commercial and federal record systems, the strongest security disclosure in this category, and an unusually explicit account of where automation stops and staff take over. Hyro is the conversational specialist, built for healthcare from inception rather than adapted, concentrated on the inbound question across call centres, websites, text and mobile. The practical split is journey against queue. If your problem is that patients are not answered when they call, Hyro is aimed at it. If it is that nothing coordinates across the appointment, the reminder, the intake and the follow up, Artera is the platform for that.
- Communication reach is the differentiator, with agents across voice, text and web reaching more than a thousand provider organisations at very large volume, and the strongest security disclosure in this category.
- Named integrations across commercial and federal record systems, which is unusual and matters for any organisation with a government facing footprint.
- The autonomy gradient is sold explicitly, with staff able to take over at any point, rather than being left for a buyer to discover in a pilot.
- It was built for healthcare conversation from inception rather than adapted, spanning call centres, websites, text and mobile with a single conversational layer.
- Its focus is the inbound question rather than outbound journey orchestration, which is where the staffing pain in most access centres actually sits.
- For an organisation whose problem is answering the phone rather than coordinating the journey, a conversational platform is the more direct purchase.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Artera and Hyro are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Artera its top capability grade on several axes, including Autonomy and Oversight Model, Security Certifications and Trust Center and EHR and Interoperability Depth. Set against Hyro, Artera grades higher on several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Hyro its top capability grade on AI Centrality, Model and Technology Transparency and EHR and Interoperability Depth. Set against Artera, Hyro grades higher on several axes, including AI Centrality, Model and Technology Transparency and Clinical and Operational Evidence. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Artera or Hyro?
On the axes where the AI Health Index separates them, Artera grades higher on several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and Security Certifications and Trust Center, and Hyro grades higher on several axes, including AI Centrality, Model and Technology Transparency and Clinical and Operational Evidence. Artera leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Artera and Hyro differ most?
The widest separation the AI Health Index records between Artera and Hyro is on Security Certifications and Trust Center, where Artera grades A and Hyro grades C. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Artera and Hyro grade the same?
The AI Health Index grades Artera and Hyro the same on several axes, including AI Safety and PHI Stewardship, HIPAA and BAA Posture and AI Liability and Recourse. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Patient Voice Agents page.
Neither vendor publishes a governance framework, model evaluation or subgroup performance analysis, and in patient communication that gap has a specific shape: an agent that performs worse for callers with accents, limited English proficiency or low health literacy fails silently, and those are the patients most likely to need the appointment. Ask both for performance by language and for the escalation rate to a human by caller segment. Neither publishes pricing. Note the name collision in searches: Artera is not ArteraAI, which is a separate oncology company.